These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26382220)

  • 1. Potential Effect of Antiplatelet and Anticoagulant Therapy on the Timing of the Diagnosis of Bladder Cancer.
    Moschini M; Karnes RJ; Suardi N; Bianchi M; Pellucchi F; Rocchini L; Damiano R; Serretta V; Salonia A; Montorsi F; Briganti A; Colombo R
    Clin Genitourin Cancer; 2016 Jun; 14(3):e245-50. PubMed ID: 26382220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the use of antithrombotic drugs be a predictive factor in the early diagnosis of bladder cancer?: A single-center analysis.
    Ekici M; Demir E; Aydin C; Çağlayan MS; Özgür BC; Baykam MM
    Medicine (Baltimore); 2024 May; 103(20):e38228. PubMed ID: 38758868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Use of Antithrombotic Medication and Hematuria-Related Complications.
    Wallis CJD; Juvet T; Lee Y; Matta R; Herschorn S; Kodama R; Kulkarni GS; Satkunasivam R; Geerts W; McLeod A; Narod SA; Nam RK
    JAMA; 2017 Oct; 318(13):1260-1271. PubMed ID: 28973248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and complications of transurethral resection of bladder tumors in patients receiving antiplatelet and/or anticoagulant therapy: a retrospective cohort study.
    Konishi T; Washino S; Nakamura Y; Ohshima M; Saito K; Arai Y; Miyagawa T
    BMC Urol; 2017 Dec; 17(1):118. PubMed ID: 29233118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does antithrombotic therapy improve survival with colorectal cancer?
    Takahashi K; Ito H; Hashimoto M; Mita K; Asakawa H; Hayashi T; Fujino K
    World J Surg Oncol; 2017 Aug; 15(1):161. PubMed ID: 28836988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer.
    Ramirez D; Gupta A; Canter D; Harrow B; Dobbs RW; Kucherov V; Mueller E; Streeper N; Uhlman MA; Svatek RS; Messing EM; Lotan Y
    BJU Int; 2016 May; 117(5):783-6. PubMed ID: 26435378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transperineal ultrasound-guided prostate biopsy is safe even when patients are on combination antiplatelet and/or anticoagulation therapy.
    Saito K; Washino S; Nakamura Y; Konishi T; Ohshima M; Arai Y; Miyagawa T
    BMC Urol; 2017 Jul; 17(1):53. PubMed ID: 28679384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of antiplatelet-anticoagulant drugs on the need of blood components transfusion after vesical transurethral resection.
    Virseda-Rodríguez AJ; Padilla-Fernández B; López-Parra M; Santos-Antunes MT; Valverde-Martínez LS; Nieto-González MJ; San Miguel-Izquierdo JF; Lorenzo-Gómez A; García-Cenador MB; Antúnez-Plaza P; Lorenzo-Gómez MF
    Arch Ital Urol Androl; 2015 Jul; 87(2):136-40. PubMed ID: 26150030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Finasteride: an effective therapeutic for benign prostatic hyperplasia related gross hematuria in patients receiving anticoagulant].
    Lin YH; Jiang YG; Li MC; Peng T
    Zhonghua Nan Ke Xue; 2009 Jan; 15(1):31-3. PubMed ID: 19288745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
    Richards KA; Ham S; Cohn JA; Steinberg GD
    Int J Urol; 2016 Jan; 23(1):42-7. PubMed ID: 26443388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early evaluation of hematuria in a patient receiving anticoagulant therapy and detection of malignancy.
    Ripley TL; Havrda DE; Blevins S; Culkin D
    Pharmacotherapy; 2004 Nov; 24(11):1638-40. PubMed ID: 15537566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
    Lee MS; Smith SD; Galor A; Hoffman GS
    Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness.
    Sevcenco S; Ponhold L; Heinz-Peer G; Fajkovic H; Haitel A; Susani M; Shariat SF; Szarvas T; Baltzer PA
    Urol Oncol; 2014 Nov; 32(8):1166-71. PubMed ID: 24962659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-Study.
    Banek S; Schwentner C; Täger D; Pesch B; Nasterlack M; Leng G; Gawrych K; Bonberg N; Johnen G; Kluckert M; Gakis G; Todenhöfer T; Hennenlotter J; Brüning T; Stenzl A;
    Urol Oncol; 2013 Nov; 31(8):1656-62. PubMed ID: 22621963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy.
    Tzoran I; Brenner B; Sakharov G; Trujillo-Santos J; Lorenzo A; Madridano O; López-Sáez JB; Monreal M;
    Eur J Intern Med; 2014 Nov; 25(9):821-5. PubMed ID: 25287697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation.
    Cohn JA; Vekhter B; Lyttle C; Steinberg GD; Large MC
    Cancer; 2014 Feb; 120(4):555-61. PubMed ID: 24496869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.
    Cha EK; Tirsar LA; Schwentner C; Hennenlotter J; Christos PJ; Stenzl A; Mian C; Martini T; Pycha A; Shariat SF; Schmitz-Dräger BJ
    World J Urol; 2012 Dec; 30(6):847-52. PubMed ID: 23124847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does antithrombotic use enable earlier diagnosis of bladder cancer? A brief institutional assessment.
    Shah YB; Clark CB; Shumaker A; Denisenko AA; Alfonsi S; Prebay Z; Schultz J; Mico V; Swaminathan V; Wang R; Mark JR; Trabulsi EJ; Lallas CD; Mann MJ; Goldberg H; Chandrasekar T
    Can J Urol; 2022 Dec; 29(6):11391-11393. PubMed ID: 36495582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria.
    Abou-El-Ghar ME; El-Assmy A; Refaie HF; El-Diasty T
    Radiology; 2009 May; 251(2):415-21. PubMed ID: 19304915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
    Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
    Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.